Mass spectrometric analysis of neuropeptidergic systems in the human pituitary and cerebrospinal fluid.
Neuropeptidergic systems have been studied in human tissues and fluids, which include the pituitary and lumbar cerebrospinal fluid, respectively. This paper reviews the qualitative and quantitative mass spectrometric analytical data obtained from three areas of study. Methionine enkephalin (ME) and beta-endorphin (BE) were quantified in the human pituitary by liquid secondary ion mass spectrometry (LSI MS)-tandem mass spectrometry. Corresponding stable isotope-incorporated synthetic peptide internal standards were used. Proenkephalin A and proopiomelanocortin produce ME and BE, respectively. The analysis of neuropeptides in macroadenomas demonstrated a decrease in both of those neuropeptidergic systems relative to controls. An analysis of prolactin-secreting microadenomas showed an increase in the proenkephalin A system. Mass spectrometry was also used to detect opioid peptide-containing proteins in the pituitary. Enzymes that process the precursors of proenkephalin A and tachykinin (substance P) neuropeptides were studied in human lumbar cerebrospinal fluid. Electrospray ionization mass spectrometry was used to characterize the molecular mass of each peptide product.
Desiderio
D M
DM
Department of Neurology, Charles B. Stout Neuroscience Mass Spectrometry Laboratory, The University of Tennessee, Memphis 38163, USA. ddesiderio@utmem.edu
D000236:Adenoma / Q000737:chemistry; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods*; D009479:Neuropeptides / Q000032:analysis* / Q000134:cerebrospinal fluid; D010902:Pituitary Gland / Q000737:chemistry*
D009479:Neuropeptides